Magnet Forensics acquired by Thoma Bravo
Goodmans LLP acted for Nellore Capital Management, the largest shareholder of Subordinate Voting Shares of Magnet Forensics, in relation to Thoma Bravo’s proposed acquisition of Magnet Forensics.
Nellore announced that it opposes the Canadian cybersecurity firm’s acquisition by Thoma Bravo on the grounds that the current price tag undervalues Magnet.
Featured Work
-
Shareholder Activism
Board of LevelJump Healthcare’s proxy defense from shareholder
Goodmans LLP in advising the Board of Directors of LevelJump Healthcare Corp. in connection with its defense of a proxy contest launched by a shareholder of LevelJump, Frank Teti… -
Shareholder Activism
Plantro Ltd. and Calian Group enter cooperation agreement
Goodmans LLP advised Plantro Ltd. in connection with entering a cooperation agreement with Calian Group Ltd. to accelerate its board renewal process and establish a temporary board committee to… -
Shareholder Activism
Plantro Ltd. completes Tender Offer and Information Services Corporation activist campaign
Goodmans LLP advised Plantro Ltd. in connection with its all-cash tender offer to acquire class A limited voting shares in the capital of Information Services Corporation (“ISC”) at a price of $30 per… -
Shareholder Activism
Algonquin Power & Utilities Corp. appoints new directors to Board and extends cooperation agreement with Starboard
Goodmans LLP advised Starboard Value LP (“Starboard”) in connection with the extension of cooperation agreement with Algonquin Power & Utilities Corp. (“Algonquin”), pursuant to which, Algonquin… -
Shareholder Activism
Board of Quipt Home Medical enters cooperation agreement with Kanen Wealth Management
Goodmans LLP represented the Board of Quipt Home Medical Corp. (or the “Board”) in connection with a notice from Philotimo Fund LP, an entity affiliated with Kanen Wealth Management LLC, announcing… -
Shareholder Activism
Roivant Sciences Ltd. announces resignation and replacement of Arbutus’ entire Board
Goodmans LLP acted for Roivant Sciences Ltd. in connection with its successful removal and replacement of all members of the Board of Directors of Arbutus Biopharma Corporation (or the “Board…